J Korean Acad Rehabil Med.  2008 Aug;32(4):469-471.

Teicoplanin-induced Elevation of Plasma Creatine Phosphokinase in the Patient with Wound Infection: A case report

Affiliations
  • 1Department of Rehabilitation Medicine, College of Medicine, The Catholic University of Korea, Korea. rokin98@catholic.ac.kr

Abstract

The use of teicoplanin is increasing with increase in the incidence of wound infections caused by methicillin-resistant Staphylococcus aureus. Teicoplanin has longer half-life than vancomycin, so it can be administerd once daily, whereas vancomycin has to be administered 3~4 times daily. Teicoplanin is known to have lesser side effect profiles than vancomycin, such as skin eruptions, ototoxicity and nephrotoxicity. A 27-year old women in vegetative state had a grade 3 pressure sore at coccyx area. We prescribe teicoplanin to manage wound infected by methicillin-resistant Staphylococcus aureus. Plasma creatine phosphokinase (CPK) was elevated abruptly at 9th day of teicoplanin therapy. Five days after discontinuation of teicoplanin, CPK was normalized. We experienced a case of elevation of plasma creatine phosphokinase associated with teicoplanin.

Keyword

Teicoplanin; Creatine phosphokinase (CPK); Pressure sore

MeSH Terms

Coccyx
Creatine
Creatine Kinase
Female
Half-Life
Humans
Incidence
Methicillin-Resistant Staphylococcus aureus
Persistent Vegetative State
Plasma
Pressure Ulcer
Skin
Teicoplanin
Vancomycin
Wound Infection
Creatine
Creatine Kinase
Teicoplanin
Vancomycin
Full Text Links
  • JKARM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr